诺诚健华(09969)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

09969 诺诚健华

已收盘 10-20 16:08:20

12.500

+0.180

+1.46%

最高12.860	最低12.180	成交量606.80万
今开12.320	昨收12.320	日振幅5.52%
总市值220.88亿	流通市值186.75亿	总股本17.67亿
成交额7,627万	换手率0.41%	流通股本14.94亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

免责声明:香港交易所资讯服务有限公司、其控股公司及／或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度，但不能保证其绝对准确和可靠，且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任（不管是否侵权法下的责任或合约责任又或其它责任）

{"stockData":{"symbol":"09969","market":"HK","secType":"STK","nameCN":"诺诚健华","latestPrice":12.5,"timestamp":1792483700007,"preClose":12.32,"halted":0,"volume":6068000,"delay":0,"changeRate":0.014610389610389588,"floatShares":1494000000,"shares":1767000000,"eps":0.4466393539120812,"marketStatus":"已收盘","change":0.18,"latestTime":"10-20 16:08:20","open":12.32,"high":12.86,"low":12.18,"amount":76270281,"amplitude":0.055195,"askPrice":12.51,"askSize":2000,"bidPrice":12.5,"bidSize":6000,"shortable":3,"etf":0,"ttmEps":0.59400448263521,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1792546200000},"marketStatusCode":5,"adr":0,"listingDate":1584892800000,"exchange":"SEHK","adjPreClose":12.32,"openAndCloseTimeList":[[1792459800000,1792468800000],[1792472400000,1792483200000]],"volumeRatio":0.981617,"lotSize":1000,"spreadScale":0,"tradeCurrency":"HKD","astockBrief":{"symbol":"688428","market":"SH","secType":"STK","nameCN":"诺诚健华","latestPrice":26.72,"timestamp":1792479600000,"preClose":26.29,"halted":0,"volume":9308400,"delay":0,"premium":"-60.20"}},"requestUrl":"/m/hq/s/09969","defaultTab":"news","newsList":[{"id":"1141349429","title":"诺诚健华（09969）拟于2026年10月27日召开第三季度业绩说明会","url":"https://stock-news.laohu8.com/highlight/detail?id=1141349429","media":"公告速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1141349429?lang=zh_cn&edition=full","pubTime":"2026-10-20 16:35","pubTimestamp":1792485334,"startTime":"0","endTime":"0","summary":"本次说明会采用网络互动形式进行。投资者可在2026年10月20日至10月26日16:00前登录上证路演中心“提问预征集”栏目或通过公司邮箱IR@innocarepharma.com提交问题，公司将在说明会上对投资者普遍关注的事项作出答复。说明会结束后，投资者可通过上证路演中心查询会议记录及主要内容。公告显示，公司董事会及全体董事确认公告内容不存在虚假记载、误导性陈述或重大遗漏，并对信息的真实性、准确性和完整性承担法律责任。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"a3893e2538b44a4c9453f52433cb6ed2","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["09969"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2676665575","title":"创新药概念强势 翰森制药（03692）涨逾7% 前三季对外技术授权约1300亿美元接近25年全年","url":"https://stock-news.laohu8.com/highlight/detail?id=2676665575","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2676665575?lang=zh_cn&edition=full","pubTime":"2026-10-20 11:23","pubTimestamp":1792466598,"startTime":"0","endTime":"0","summary":"金吾财讯 | 创新药概念强势，截至发稿，乐普生物 涨8.81%，翰森制药涨7.06%，药明生物涨6.74%，晶泰控股涨4.56%，康诺亚-B涨4.70%，亚盛医药涨4.30%，恒瑞医药涨4.16%，药明合联涨3.96%，云顶新耀涨3.89%，和黄医药涨3.68%，中国生物制药涨3.24%，石药集团涨3.16%，科伦博泰生物涨3.14%，诺诚健华涨3.08%。消息面上，据人民财讯，10月20日，国家发展改革委召开10月份新闻发布会，会上提到，我国前三季度创新药对外技术授权约1300亿美元，接近去年全年。","market":"sg","thumbnail":"https://static.szfiu.com/news/20200908/YzIxOTk5NDIxODE3ODE=.png","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20200908/YzIxOTk5NDIxODE3ODE=.png"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"299f0a9977df499f8ead781071e5e5e7","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1993987","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1242518931.SGD","BK1576","06990","06978","02157","LU0128522744.USD","LU0359201885.HKD","LU0979878070.USD","LU0417516738.SGD","LU0052750758.USD","LU0211977185.USD","LU1152091754.HKD","KURE","02162","02228","LU0196878994.USD","LU1008478684.HKD","MEDX","IBBQ","02269","LU0417516902.SGD","06855","BK1589","LU0072913022.USD","LU1794554557.SGD","LU0043850808.USD","BK1161","159992","02268","LU1226288170.HKD","BK1521","LU2488822045.USD","LU2543165471.USD","01093","LU0348827113.USD","LU1993786604.SGD","LNGR","LU1188198961.HKD","03692","01952","01276","00013","01177","BK1610","LU1720050803.USD","IE0008369823.USD","LU2476274720.SGD","LU1242518857.USD","LU0588546209.SGD","09969"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2676690684","title":"诺诚健华（688428）披露召开2026年第三季度业绩说明会公告，10月19日股价上涨1.08%","url":"https://stock-news.laohu8.com/highlight/detail?id=2676690684","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2676690684?lang=zh_cn&edition=full","pubTime":"2026-10-19 22:33","pubTimestamp":1792420400,"startTime":"0","endTime":"0","summary":"截至2026年10月19日收盘，诺诚健华报收于26.29元，较前一交易日上涨1.08%，最新总市值为465.25亿元。该股当日开盘25.81元，最高27.2元，最低25.71元，成交额达2.75亿元，换手率为3.8%。公告显示，公司将于2026年10月27日上午11:00-12:00通过上证路演中心网络互动方式召开2026年第三季度业绩说明会，介绍公司当季经营成果及财务状况。投资者可于2026年10月20日至10月26日16:00前通过上证路演中心网站或公司邮箱IR@innocarepharma.com提问。会后可通过上证路演中心查看会议情况。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026101900030181.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","09969","BK1161","BK1574","688428"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2675361897","title":"股市必读：诺诚健华新发布《港股公告：董事会召开日期》","url":"https://stock-news.laohu8.com/highlight/detail?id=2675361897","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2675361897?lang=zh_cn&edition=full","pubTime":"2026-10-14 02:03","pubTimestamp":1791914590,"startTime":"0","endTime":"0","summary":"截至2026年10月13日收盘，诺诚健华报收于26.37元，下跌2.15%，换手率3.13%，成交量8.55万手，成交额2.25亿元。当日关注点交易信息汇总：10月13日主力资金净流入660.78万元，游资资金净流入2261.25万元，散户资金净流出2922.02万元。公司公告汇总：诺诚健华董事会将于2026年10月26日召开会议，审议截至2026年9月30日止九个月的第三季度未经审计业绩。董事会成员包括崔霁松博士、赵仁滨博士、施一公博士、谢榕刚先生、胡兰女士、董丹丹博士及管坤良教授。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026101400001707.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK1161","BK0239","BK1574","688428","09969"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2675804961","title":"股市必读：诺诚健华新发布《港股公告：董事会召开日期》","url":"https://stock-news.laohu8.com/highlight/detail?id=2675804961","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2675804961?lang=zh_cn&edition=full","pubTime":"2026-10-13 01:47","pubTimestamp":1791827233,"startTime":"0","endTime":"0","summary":"截至2026年10月12日收盘，诺诚健华报收于26.95元，下跌4.16%，换手率2.98%，成交量8.16万手，成交额2.24亿元。当日关注点交易信息汇总：10月12日主力资金净流入548.7万元，占总成交额2.45%。公司公告汇总：诺诚健华董事会将于2026年10月26日召开会议，审议截至2026年9月30日止九个月的第三季度未经审计业绩。董事会成员包括崔霁松博士、赵仁滨博士、施一公博士、谢榕刚先生、胡兰女士、董丹丹博士及管坤良教授。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026101300001830.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["09969","BK1161","BK1574","BK0239","688428"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1114315912","title":"诺诚健华医药（09969）定于10月26日召开董事会 审议2026年前三季度业绩","url":"https://stock-news.laohu8.com/highlight/detail?id=1114315912","media":"公告速递","labels":["dataReport","SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1114315912?lang=zh_cn&edition=full","pubTime":"2026-10-12 16:43","pubTimestamp":1791794595,"startTime":"0","endTime":"0","summary":"诺诚健华医药有限公司（09969）10月12日发布公告称，公司董事会将于2026年10月26日（星期一）召开会议，主要议程包括审议并批准公司及其附属公司截至2026年9月30日止九个月的未经审计第三季度业绩及其发布事宜。\n根据公告，截至本公告日期，公司董事会成员包括：主席兼执行董事崔霽松博士，执行董事赵仁滨博士，非执行董事施一公博士及谢榕刚先生，以及独立非执行董事胡兰女士、董丹丹博士和管坤良教授。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["09969"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2674896607","title":"财报扭亏、重磅合作落地 诺诚健华创始家族为何轮番减持？","url":"https://stock-news.laohu8.com/highlight/detail?id=2674896607","media":"新浪证券","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2674896607?lang=zh_cn&edition=full","pubTime":"2026-10-10 14:36","pubTimestamp":1791614160,"startTime":"0","endTime":"0","summary":"然而，靓丽财报的另一面，是公司两大创始人家族轮番减持。9月24日，公司宣布与礼来达成总潜在金额33.5亿美元的重磅研发合作仅6天后，崔霁松家族即通过港股减持500万股。财报扭亏、重磅合作落地双创始家族为何轮番套现诺诚健华由崔霁松与施一公于2015年联合创立，成立之初便形成了清晰的双家族持股架构。施一公家族的减持最早启动于2026年二季度。第二轮减持则发生在重磅合作公布之后。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/observe/2026-10-10/doc-iniutkci6118384.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["09969","688428"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2674188261","title":"生物医药板块继续回调 恒生生物科技指数跌2.31%","url":"https://stock-news.laohu8.com/highlight/detail?id=2674188261","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2674188261?lang=zh_cn&edition=full","pubTime":"2026-10-09 10:17","pubTimestamp":1791512279,"startTime":"0","endTime":"0","summary":"金吾财讯 | 生物医药板块继续回调，恒生生物科技指数跌2.31%，恒生医疗保健指数跌2.09%。个股方面，复宏汉霖（02696）跌4.84%，药明康德（02359）跌3.92%，药明合联（02268）跌3.47%，泰格医药（03347）跌3.35%，诺诚健华（09969）跌3.27%，药明生物（02269）跌3.33%，金斯瑞生物科技（01548）跌3.10%，康诺亚-B（02162）跌2.58%，百济神州（06160）跌2.44%。","market":"fut","thumbnail":"https://static.szfiu.com/news/20241108/OWU0MGRiNDM1NDA5NTM4MzU5OQ==.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20241108/OWU0MGRiNDM1NDA5NTM4MzU5OQ==.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1993377","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02696","399441","LU0181495838.USD","LU2488822045.USD","02268","LU1880383366.USD","LU2778985437.USD","SG9999002463.SGD","LU0856984785.SGD","LU0348825331.USD","LU0417516738.SGD","LU0359202008.SGD","LU2045819591.USD","02162","BK1521","BK4588","LU1688375341.USD","IE00B0JY6N72.USD","02359","LU0320764243.SGD","BK1161","LU0540923850.HKD","LU2039709279.SGD","SG9999014674.SGD","HK0000320264.USD","LU0417516902.SGD","BK1141","03347","KURE","XBI","LU0463099449.HKD","02269","BK4581","01548","LU1251922891.USD","LU0561508036.HKD","LU0516422440.USD","09969","LU0327786744.USD","LU2242644610.SGD","06160","BK1576","LU2125910500.SGD","LU1831875114.USD","161726","HK0000306685.HKD","LU0588546209.SGD","LU0320764599.SGD","LU0128522744.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2674378889","title":"诺诚健华（688428）10月8日主力资金净买入6125.32万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2674378889","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2674378889?lang=zh_cn&edition=full","pubTime":"2026-10-09 08:28","pubTimestamp":1791505737,"startTime":"0","endTime":"0","summary":"证券之星消息，截至2026年10月8日收盘，诺诚健华报收于27.03元，下跌7.15%，换手率8.69%，成交量23.75万手，成交额6.49亿元。近5日资金流向一览见下表：诺诚健华融资融券信息显示，融资方面，当日融资买入4239.44万元，融资偿还4794.74万元，融资净偿还555.3万元。诺诚健华主营业务：主要从事生物医药研发、生产和商业化。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026100900006145.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK1161","09969","BK1574","BK0239","688428"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673027651","title":"10月8日诺诚健华跌7.15%，富国精准医疗混合A基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2673027651","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2673027651?lang=zh_cn&edition=full","pubTime":"2026-10-08 16:40","pubTimestamp":1791448844,"startTime":"0","endTime":"0","summary":"证券之星消息，10月8日诺诚健华跌7.15%，收盘报27.03元，换手率8.69%，成交量23.75万手，成交额6.49亿元。根据2026基金半年报公募基金重仓股数据，重仓该股的公募基金共35家，其中持有数量最多的公募基金为富国基金的富国精准医疗混合A。富国精准医疗混合A目前规模为28.98亿元，最新净值3.2487，较上一交易日上涨2.6%，近一年下跌8.34%。富国精准医疗混合A的前十大重仓股如下：以上内容为证券之星据公开信息整理，仅供参考不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026100800021330.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["09969","688428","BK0239","BK1574","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1122675402","title":"异动解读｜诺诚健华盘中下跌5.11%，股东密集减持叠加板块回调拖累","url":"https://stock-news.laohu8.com/highlight/detail?id=1122675402","media":"行情直击","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1122675402?lang=zh_cn&edition=full","pubTime":"2026-10-08 10:37","pubTimestamp":1791427077,"startTime":"0","endTime":"0","summary":"10月8日，诺诚健华盘中下跌5.11%，报12.82港元，成交额6768.14万港元。消息面上，公司近日披露持股5%以上股东Sunland BioMed Ltd及其一致行动人合计持股比例由7.23%降至6.94%，叠加Jisong Cui、Renbin Zhao等多位股东于9月30日集中减持，市场对内部人持续套现的担忧升温。此外，生物医药板块整体走弱，恒生生物科技指数前一日跌3.15%，行业情绪转弱对个股形成明显压制。此前公司与礼来达成的最高33.5亿美元研发合作利好已被短期涨幅消化，获利了结压力上升。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"诺诚健华盘中下跌，股东密集减持引关注","news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["09969"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673017467","title":"股市必读：诺诚健华新发布《诺诚健华医药有限公司关于持股5%以上股东权益变动触及1%刻度的提示性公告》","url":"https://stock-news.laohu8.com/highlight/detail?id=2673017467","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2673017467?lang=zh_cn&edition=full","pubTime":"2026-10-08 03:19","pubTimestamp":1791400748,"startTime":"0","endTime":"0","summary":"公司公告汇总诺诚健华医药有限公司关于持股5%以上股东权益变动触及1%刻度的提示性公告诺诚健华医药有限公司持股5%以上股东Sunland BioMed Ltd及其一致行动人Stanley Holdings Limited、The Jisong Cui 2019 Irrevocable Trust、Jisong Cui（崔霁松）及直系亲属合计持股比例由7.23%减少至6.94%，持股数量由12,786.4032万股减少至12,286.4032万股。本次权益变动因Jisong Cui（崔霁松）个人资金需求所致，不触及要约收购，未违反承诺，不影响公司控制权及治理结构。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026100800001585.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK1515","159938","BK0239","BK1574","BK1161","09969","688428","09939"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1162173796","title":"异动解读｜诺诚健华盘中下跌5.01%，生物医药板块整体回调拖累","url":"https://stock-news.laohu8.com/highlight/detail?id=1162173796","media":"行情直击","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1162173796?lang=zh_cn&edition=full","pubTime":"2026-10-07 09:47","pubTimestamp":1791337655,"startTime":"0","endTime":"0","summary":"10月7日，诺诚健华盘中下跌5.01%，报13.27港元，成交额385.25万港元。消息面上，生物医药板块当日整体大幅回调，恒生生物科技指数跌3.15%，恒生医疗保健指数跌2.73%，行业情绪转弱对个股形成明显拖累。此前公司于9月底与礼来达成最高33.5亿美元研发合作，但该利好已被短期涨幅消化，叠加近期多家股东相继披露减持，市场获利了结压力有所上升。（以上内容均基于市场公开消息，由程序或算法智能生成，仅作为股价异动提醒，不作为投资建议或交易依据。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"诺诚健华下跌，生物医药板块回调拖累","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["09969"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673064659","title":"生物医药板块大幅回调 恒生生物科技指数跌3.15%","url":"https://stock-news.laohu8.com/highlight/detail?id=2673064659","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2673064659?lang=zh_cn&edition=full","pubTime":"2026-10-07 09:35","pubTimestamp":1791336927,"startTime":"0","endTime":"0","summary":"金吾财讯 | 生物医药板块大幅回调，截至发稿，恒生生物科技指数跌3.15%，恒生医疗保健指数跌2.73%，万得港股中国创新药指数跌2.39%。个股方面，金斯瑞生物科技（01548）跌14.81%，再鼎医药（09688）跌4.47%，药明合联（02268）跌3.68%，药明生物（02269）跌2.50%，百济神州（06160）跌1.18%，诺诚健华（09969）跌1.43%，康诺亚-B（02162）跌1.32%，康方生物（09926）跌1.45%。","market":"nz","thumbnail":"https://static.szfiu.com/news/20210810/Y2E2NzVmYjg0MWU1MjU0NDY3MDY2MjI=.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20210810/Y2E2NzVmYjg0MWU1MjU0NDY3MDY2MjI=.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1993174","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1880383366.USD","SG9999002463.SGD","LU0456827905.SGD","LU0572944931.SGD","BK1141","02268","09688","LU0244354667.USD","LU0320764243.SGD","LU0856984785.SGD","LU0052750758.USD","LU0211977185.USD","LU1242518857.USD","BK1574","LU0348825331.USD","IE00B543WZ88.USD","LU1794554557.SGD","06160","LU3063872942.SGD","09969","LU0516423174.USD","LU0228659784.USD","LU1720050803.USD","LU0417516738.SGD","LU0456846285.SGD","LU0588546209.SGD","01548","XBI","LU0359202008.SGD","161726","BK1161","LU2488822045.USD","LU0348784397.USD","KURE","LU2039709279.SGD","IE00B0JY6N72.USD","BK1521","399441","LU1242518931.SGD","SG9999014674.SGD","LU0561508036.HKD","LU0348766576.USD","02269","BK4588","SG9999002562.SGD","LU0320764599.SGD","09926","LU0828237510.HKD","02162"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673058257","title":"【热门行业】光遗传学获2026年诺奖：产业仍处早期，眼科赛道临床进度领先（附相关标的）","url":"https://stock-news.laohu8.com/highlight/detail?id=2673058257","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2673058257?lang=zh_cn&edition=full","pubTime":"2026-10-06 18:22","pubTimestamp":1791282120,"startTime":"0","endTime":"0","summary":"诺奖落地的消息引发市场对光遗传学、脑科学相关赛道的关注。从行业发展阶段来看，光遗传学整体仍处于产业化早期，基础科研仍是核心需求，临床商业化尚未全面兑现。下游临床应用端，眼科赛道临床进度相对领先，但全行业目前尚无光遗传学产品完成全流程审批并获批上市，从临床试验到产品上市仍存在重大不确定性。","market":"us","thumbnail":"https://static.szfiu.com/news/20250110/YWU1MjY3ODMwOTg1Nzg=.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20250110/YWU1MjY3ODMwOTg1Nzg=.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1993152","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1191","09969","LU0823426308.USD","LU0516423174.USD","LU0307460666.USD","LU0708995153.HKD","IBBQ","LU0708995583.HKD","BK1588","LU0128522744.USD","LU0516423091.SGD","LU0516422440.USD","HK0000306685.HKD","LU0052750758.USD","LU0819121731.USD","LU0348767384.USD","LU1961090484.USD","LU0051755006.USD","01477","HK0000320264.USD","LU0211977185.USD","LU0417516902.SGD","LU0456846285.SGD","LU0043850808.USD","09926","IE00B0JY6N72.USD","LU0181495838.USD","LU1688375341.USD","01952","LU0140636845.USD","LU0029874905.USD","BK1576","LU1242518931.SGD","LU0359202008.SGD","BK1161","01548","LU0456827905.SGD","02228","09688","LU0540923850.HKD","LU0572944931.SGD","LU0979878070.USD","02269","LU1720050803.USD","BK1574","LU2476274308.USD","LU0634319403.HKD","KURE","LU1794554557.SGD","LU0359201612.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1108571752","title":"诺诚健华更新9月股份变动月报表，内地上市股份增发581,137股","url":"https://stock-news.laohu8.com/highlight/detail?id=1108571752","media":"公告速递","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1108571752?lang=zh_cn&edition=full","pubTime":"2026-10-06 16:47","pubTimestamp":1791276451,"startTime":"0","endTime":"0","summary":"诺诚健华于2026年10月6日发布截至2026年9月30日止月份证券变动月报，根据公告，公司注册股本维持25,000,000,000股普通股，面值每股USD0.000002，注册股本总额为USD50,000，报告期内无增减变化。股份期权与限制性股票方面，主要变化来自于2024年人民币股股份激励计划：公司于2026年9月17日向激励对象预留授予581,137股限制性股票，每股限制性股票的价格为人民币6.65元。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["09969"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673193031","title":"港股异动 | 诺诚健华(09969.HK)午后涨超5% 近期与礼来签订重磅协议 公司出海进程再加速","url":"https://stock-news.laohu8.com/highlight/detail?id=2673193031","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2673193031?lang=zh_cn&edition=full","pubTime":"2026-10-06 14:39","pubTimestamp":1791268794,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK1574","09969","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1186056697","title":"异动解读｜诺诚健华盘中上涨5.01%，生物科技板块回暖带动反弹","url":"https://stock-news.laohu8.com/highlight/detail?id=1186056697","media":"行情直击","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1186056697?lang=zh_cn&edition=full","pubTime":"2026-10-06 13:55","pubTimestamp":1791266132,"startTime":"0","endTime":"0","summary":"10月6日，诺诚健华盘中上涨5.01%，报14.04港元，成交额1631.85万港元。生物科技板块整体回暖，康希诺生物涨13.03%，康方生物涨4.43%，三生制药涨2.83%，信达生物涨2.26%，百济神州涨0.46%，板块情绪回升带动个股反弹。此前公司披露大股东Sunland BioMed Ltd减持500万股，持股比例由7.23%降至6.94%，该利空于前几个交易日已有所消化。公司与礼来达成的33.5亿美元研发合作及授权许可协议持续提供基本面支撑，市场关注度较高。（以上内容均基于市场公开消息，由程序或算法智能生成，仅作为股价异动提醒，不作为投资建议或交易依据。）","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"诺诚健华盘中上涨，生物科技板块回暖","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["09969"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673033818","title":"生物医药板块走高 恒生生物科技指数涨2.32% 金斯瑞生物科技（01548）涨5.30%","url":"https://stock-news.laohu8.com/highlight/detail?id=2673033818","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2673033818?lang=zh_cn&edition=full","pubTime":"2026-10-06 10:01","pubTimestamp":1791252073,"startTime":"0","endTime":"0","summary":"金吾财讯 | 生物医药板块走高，恒生生物科技指数涨2.32%，恒生医疗保健指数涨2.19%，万得中国创新药指数涨2.15%。个股方面，再鼎医药涨6.97%，金斯瑞生物科技涨5.30%，君实生物涨3.07%，药明生物涨3.07%，康方生物涨2.92%，康诺亚-B涨2.33%，泰格医药涨1.90%，诺诚健华涨1.87%。","market":"sg","thumbnail":"https://static.szfiu.com/news/20241108/MGY1NDA5NTM4NDQ4Mw==.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20241108/MGY1NDA5NTM4NDQ4Mw==.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1993104","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1794554557.SGD","BK1515","SG9999002463.SGD","HK0000320223.HKD","IE00B543WZ88.USD","SG9999002562.SGD","LU0051755006.USD","03347","399441","LU0327786744.USD","01548","BK4581","KURE","LU0052750758.USD","LU0456827905.SGD","01877","LU0561508036.HKD","LU0359202008.SGD","HK0000306701.USD","LU0516423174.USD","LU0348784397.USD","LU2778985437.USD","LU1720050803.USD","LU0516422952.EUR","LU2039709279.SGD","IE00BPRC5H50.USD","LU0181495838.USD","LU1242518857.USD","LU1880383366.USD","XBI","LU0708995583.HKD","LU0417516902.SGD","02269","02162","LU0320764599.SGD","LU0039217434.USD","LU0128522744.USD","LU0140636845.USD","09926","09969","BK1141","LU0634319403.HKD","LU2488822045.USD","09688","LU0307460666.USD","BK1574","LU0708995153.HKD","161726","LU0348735423.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1199194956","title":"诺诚华：Renbin Zhao减持，好仓比例降至6.27%","url":"https://stock-news.laohu8.com/highlight/detail?id=1199194956","media":"港股披露","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1199194956?lang=zh_cn&edition=full","pubTime":"2026-10-02 17:51","pubTimestamp":1790934718,"startTime":"0","endTime":"0","summary":"Renbin Zhao于2026年9月30日在联交所场内以主动交易方式（即二级市场直接买卖）减持诺诚华股份500.00万股，属场内主动交易。Renbin Zhao此次减持前持有诺诚华好仓1.16亿股，占比6.55%；减持后持股量为1.11亿股，好仓比例降至6.27%。原文链接：Hong Kong Exchanges and Clearing Limited","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["09969"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"https://cn.innocarepharma.com","stockEarnings":[{"period":"1week","weight":-0.0322},{"period":"1month","weight":-0.1776},{"period":"3month","weight":-0.1079},{"period":"6month","weight":-0.2163},{"period":"1year","weight":-0.1573},{"period":"ytd","weight":0.0016}],"compareEarnings":[{"period":"1week","weight":-0.001},{"period":"1month","weight":-0.0213},{"period":"3month","weight":-0.0153},{"period":"6month","weight":-0.0754},{"period":"1year","weight":-0.0657},{"period":"ytd","weight":-0.0563}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"诺诚健华医药有限公司是一家主要从事生物医药研发、生产和商业化的中国公司。该公司专注于肿瘤和自身免疫性疾病等存在未满足临床需求的领域。该公司的主要产品管线包括奥布替尼、Tafasitamab、ICP-490、ICP-B02、ICP-248、ICP-B05、ICP-332、ICP-488、ICP-192、ICP-723、ICP-033和ICP-189等。其产品主要用于治疗血液瘤、实体瘤和自身免疫疾病。该公司还在开发用于治疗由T细胞功能异常所导致的自身免疫性疾病的产品。该公司在国内和国外市场开展业务。","yearOnYearQuotes":[{"month":1,"riseRate":0.166667,"avgChangeRate":-0.103999},{"month":2,"riseRate":0.666667,"avgChangeRate":0.128923},{"month":3,"riseRate":0.166667,"avgChangeRate":-0.010195},{"month":4,"riseRate":0.714286,"avgChangeRate":0.102464},{"month":5,"riseRate":0.142857,"avgChangeRate":-0.059233},{"month":6,"riseRate":0.857143,"avgChangeRate":0.113731},{"month":7,"riseRate":0.571429,"avgChangeRate":0.05509},{"month":8,"riseRate":0.285714,"avgChangeRate":-0.06378},{"month":9,"riseRate":0.428571,"avgChangeRate":-0.016143},{"month":10,"riseRate":0.285714,"avgChangeRate":-0.0524},{"month":11,"riseRate":0.833333,"avgChangeRate":0.100833},{"month":12,"riseRate":0.5,"avgChangeRate":-0.012645}],"exchange":"SEHK","name":"诺诚健华","nameEN":"INNOCARE"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.52.0","shortVersion":"4.52.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"诺诚健华(09969)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供诺诚健华(09969)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"诺诚健华,09969,诺诚健华股票,诺诚健华股票老虎,诺诚健华股票老虎国际,诺诚健华行情,诺诚健华股票行情,诺诚健华股价,诺诚健华股市,诺诚健华股票价格,诺诚健华股票交易,诺诚健华股票购买,诺诚健华股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"诺诚健华(09969)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供诺诚健华(09969)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}